Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice
Elizabeth A. Wohlfert, … , Jinfang Zhu, Yasmine Belkaid
Elizabeth A. Wohlfert, … , Jinfang Zhu, Yasmine Belkaid
Published October 3, 2011
Citation Information: J Clin Invest. 2011;121(11):4503-4515. https://doi.org/10.1172/JCI57456.
View: Text | PDF
Research Article Immunology

GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice

  • Text
  • PDF
Abstract

Tregs not only keep immune responses to autoantigens in check, but also restrain those directed toward pathogens and the commensal microbiota. Control of peripheral immune homeostasis by Tregs relies on their capacity to accumulate at inflamed sites and appropriately adapt to their local environment. To date, the factors involved in the control of these aspects of Treg physiology remain poorly understood. Here, we show that the canonical Th2 transcription factor GATA3 is selectively expressed in Tregs residing in barrier sites including the gastrointestinal tract and the skin. GATA3 expression in both murine and human Tregs was induced upon TCR and IL-2 stimulation. Although GATA3 was not required to sustain Treg homeostasis and function at steady state, GATA3 played a cardinal role in Treg physiology during inflammation. Indeed, the intrinsic expression of GATA3 by Tregs was required for their ability to accumulate at inflamed sites and to maintain high levels of Foxp3 expression in various polarized or inflammatory settings. Furthermore, our data indicate that GATA3 limits Treg polarization toward an effector T cell phenotype and acquisition of effector cytokines in inflamed tissues. Overall, our work reveals what we believe to be a new facet in the complex role of GATA3 in T cells and highlights what may be a fundamental role in controlling Treg physiology during inflammation.

Authors

Elizabeth A. Wohlfert, John R. Grainger, Nicolas Bouladoux, Joanne E. Konkel, Guillaume Oldenhove, Carolina Hager Ribeiro, Jason A. Hall, Ryoji Yagi, Shruti Naik, Ravikiran Bhairavabhotla, William E. Paul, Remy Bosselut, Gang Wei, Keji Zhao, Mohamed Oukka, Jinfang Zhu, Yasmine Belkaid

×

Figure 1

Dermis and gut Lp Tregs express high levels of GATA3.

Options: View larger image (or click on image) Download as PowerPoint
Dermis and gut Lp Tregs express high levels of GATA3.
(A) Gut Tregs expr...
(A) Gut Tregs express RORγt and GATA3. Cells were harvested from SILp, stained for T-bet, RORγt, GATA3, and Foxp3, and assessed by flow cytometry. Plots are gated on live CD4+TCR-β+ cells; isotype for RORγt. (B) GATA3 is highly expressed in dermis Tregs. Cells were harvested from spleen and ear pinna, stained for GATA3 and Foxp3, and assessed by flow cytometry. Plots are gated on live CD4+TCR-β+ cells. Numbers in quadrants refer to the percentage of each subset. (C) Barrier tissue resident Tregs express higher levels of GATA3 than peripheral Tregs. Percentages of Foxp3+CD4+TCRβ+ cells expressing GATA3 in spleen (Spln), peripheral LN (PLN), lung, liver, mesenteric LN (MLN), Peyer patches (PP), SILp, colon Lp, and dermis. **P < 0.001. n = 3 mice per group. Data are presented as mean ± SEM. (D) Nuclear localization of GATA3. Foxp3eGFP+ cells were purified by sorting from the SILp of naive Foxp3eGFP mice and stained for Foxp3 (green), GATA3 (red), and Hoescht (blue), and localization of proteins was assessed by confocal microscopy. Right image is enlargement of top left image. Scale bars: 5 μm. (E) GATA3 is expressed by dermis Tregs in rhesus macaque. Cells were harvested from the dermis and stained for CD3, GATA3, and Foxp3. Number refers to frequency of GATA3+ cells. Plot is gated on live Foxp3+CD3+CD8– cells (filled histogram, isotype control; open histogram, GATA3). Data shown are representative of 3 independent experiments (A and B) and 1 experiment (E) with similar results.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts